An analysis of original research contributions toward FDA-approved drugs

Drug Discovery Today

Volumn 20, Issue 10, 2015, Pages 1182-1187

  Patridge, Eric V ^a   Gareiss, Peter C ^a   Kinch, Michael S ^b   Hoyer, Denton W ^a  

^a YALE UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG APPROVAL; DRUG MARKETING; DRUG RESEARCH; FOOD AND DRUG ADMINISTRATION; HIGH THROUGHPUT SCREENING; PUBLICATION; PUBLISHING; REVIEW; DRUG DEVELOPMENT; DRUG INDUSTRY; HUMAN; TIME FACTOR; TRENDS; UNITED STATES;

DRUG APPROVAL; DRUG DISCOVERY; DRUG INDUSTRY; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; TIME FACTORS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84944513136     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2015.06.006     Document Type: Short Survey

References (29)

1. J. Drews Drug discovery: a historical perspective Science 287 2000 1960 1964
2. D.J. Newman, and G.M. Cragg Natural products as sources of new drugs over the 30 years from 1981 to 2010 J. Nat. Prod. 75 2012 311 335
3. B. Munos Lessons from 60 years of pharmaceutical innovation Nat. Rev. Drug. Discov. 8 2009 959 968
4. K.I. Kaitin, and J.A. DiMasi Pharmaceutical innovation in the 21st century: new drug approvals in the first decade, 2000-2009 Clin. Pharmacol. Ther. 89 2011 183 188
5. M.S. Kinch, and et al. An overview of FDA-approved new molecular entities: 1827-2013 Drug Discov. Today 19 2014 1033 1039
6. E. Patridge, and et al. An analysis of FDA-approved drugs: natural products and their derivatives Drug Discov. Today 2015 Published online January 21, 2015. http://dx.doi.org/10.1016/j.drudis.2015.01.009
7. Boerhaave, H. (1727) Process 98: the native salt of urine. In Elementa Chemiae (2nd edn) (Boerhaave, H., ed.), pp. 317-318, Caspar Fritsch
8. G. Barger, and A.J. Ewins CCXXXVII. Some phenolic derivatives of β-phenylethylamine J. Chem. Soc. Trans. 97 1910 2253 2261
9. A.S. Pina, and et al. An historical overview of drug discovery A.C.A. Roque, Ligand-macromolecular interactions in drug discovery 2010 Humana Press New York 3 12
10. Y.C. Martin Accomplishments and challenges in integrating software for computer-aided ligand design in drug discovery Perspect. Drug Discov. Design 3 1995 139 150
11. M.S. Kinch The rise (and decline?) of biotechnology Drug Discov. Today 19 2014 1686 1690
12. F.F. Runge Neueste phytochemische Entdeckungen zur Begründung einer wissenschaftlichen Phytochemie 1820 Reimer
13. C.J. Tralau-Stewart, and et al. Drug discovery: new models for industry-academic partnerships Drug Discov. Today 14 2009 95 101
14. A.P. Kozikowski, and et al. Why academic drug discovery makes sense Science 313 2006 1235 1236
15. A.K. Rai, and et al. Pathways across the valley of death: novel intellectual property strategies for accelerated drug discovery Yale J. Health Policy Law Ethics 8 2008 53 89
16. M.A. Hamburg, and F.S. Collins The path to personalized medicine N. Engl. J. Med. 363 2010 301 304
17. D. Butler Translational research: crossing the valley of death Nat. News 453 2008 840 842
18. T. Melese, and et al. Open innovation networks between academia and industry: an imperative for breakthrough therapies Nat. Med. 15 2009 502 507
19. A. Edwards Open-source science to enable drug discovery Drug Discov. Today 13 2008 731 733
20. J.G. Lombardino, and J.A. Lowe The role of the medicinal chemist in drug discovery: then and now Nat. Rev. Drug. Discov. 3 2004 853 862
21. J.W. Scannell, and et al. Diagnosing the decline in pharmaceutical R&D efficiency Nat. Rev. Drug. Discov. 11 2012 191 200
22. S. Ekins, and et al. Four disruptive strategies for removing drug discovery bottlenecks Drug Discov. Today 18 2013 265 271
23. J.A. Frearson, and I.T. Collie HTS and hit finding in academia: from chemical genomics to drug discovery Drug Discov. Today 14 2009 1150 1158
24. B.S. Slusher, and et al. Bringing together the academic drug discovery community Nat. Rev. Drug. Discov. 12 2013 811 812
25. S. Frye, and et al. US academic drug discovery Nat. Rev. Drug. Discov. 10 2011 409 410
26. T.I. Oprea, and et al. A crowdsourcing evaluation of the NIH chemical probes Nat. Chem. Biol. 5 2009 441 447
27. H.S. Kirkegaard, and F. Valentin Academic drug discovery centres: the economic and organisational sustainability of an emerging model Drug Discov. Today 19 2014 1699 1710
28. R. Peter, and A. Roy A roadmap for achieving self-sustainability of academic high throughput screening core facilities Drug Discov. 12 2011 59
29. W.L. Jorgensen Challenges for academic drug discovery Angew. Chem. Int. Ed. 51 2012 11680 11684